HomeHOWL • NASDAQ
Werewolf Therapeutics Inc
Follow
$1.21
1.63%
After Hours:(0.00%)0.00
$1.21
Closed: Mar 13, 4:02:27 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 7.97M | 3.68% |
Net income | -20.40M | -69.96% |
Net profit margin | — | — |
Earnings per share | -0.46 | -39.39% |
EBITDA | -19.91M | -59.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 111.00M | -17.38% |
Total assets | 126.93M | -27.40% |
Total liabilities | 53.54M | -15.63% |
Total equity | 73.39M | — |
Shares outstanding | 44.83M | — |
Price to book | 0.75 | — |
Return on assets | -38.11% | — |
Return on capital | -42.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -20.40M | -69.96% |
Cash from operations | -14.25M | -210.84% |
Cash from investing | -123.00K | 37.88% |
Cash from financing | 2.55M | -71.93% |
Net change in cash | -11.83M | -375.71% |
Free cash flow | -7.87M | -428.48% |
Previous close
$1.23
Day range
$1.20 - $1.26
Year range
$1.03 - $6.89
Market cap
53.92M USD
Avg Volume
263.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
46